137 related articles for article (PubMed ID: 30104077)
1. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis.
Dousti F; Shahrisa A; Ansari H; Hajjari M; Tahmasebi Birgani Y; Mohammadiasl J; Tahmasebi Birgani M
Pathol Res Pract; 2018 Sep; 214(9):1462-1466. PubMed ID: 30104077
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma.
Verma A; Jiang Y; Du W; Fairchild L; Melnick A; Elemento O
Genome Med; 2015 Nov; 7():110. PubMed ID: 26521025
[TBL] [Abstract][Full Text] [Related]
3. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma.
Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C
Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571
[TBL] [Abstract][Full Text] [Related]
4. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma.
Sun J; Cheng L; Shi H; Zhang Z; Zhao H; Wang Z; Zhou M
Sci Rep; 2016 Jun; 6():27842. PubMed ID: 27292966
[TBL] [Abstract][Full Text] [Related]
5. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
[TBL] [Abstract][Full Text] [Related]
6. Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma.
Gao HY; Wu B; Yan W; Gong ZM; Sun Q; Wang HH; Yang W
Oncol Rep; 2017 Sep; 38(3):1363-1372. PubMed ID: 28713985
[TBL] [Abstract][Full Text] [Related]
7. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma.
Yan Y; Han J; Li Z; Yang H; Sui Y; Wang M
Mol Med Rep; 2016 Jun; 13(6):5125-31. PubMed ID: 27122348
[TBL] [Abstract][Full Text] [Related]
8. The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma.
Zhao S; Fang S; Liu Y; Li X; Liao S; Chen J; Liu J; Zhao L; Li H; Zhou W; Shen W; Dong X; Xiang R; Wang L; Zhao Y
Oncotarget; 2017 May; 8(21):34374-34386. PubMed ID: 28423735
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA HULC predicts poor clinical outcome and represents pro-oncogenic activity in diffuse large B-cell lymphoma.
Peng W; Wu J; Feng J
Biomed Pharmacother; 2016 Apr; 79():188-93. PubMed ID: 27044827
[TBL] [Abstract][Full Text] [Related]
10. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma.
Deng L; Jiang L; Tseng KF; Liu Y; Zhang X; Dong R; Lu Z; Wang X
Cancer Biomark; 2018; 23(2):157-164. PubMed ID: 30175971
[TBL] [Abstract][Full Text] [Related]
11. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.
Peng W; Wu J; Feng J
Clin Exp Med; 2017 Feb; 17(1):1-8. PubMed ID: 26475621
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA as a novel biomarker and therapeutic target in aggressive B-cell non-Hodgkin lymphoma: A systematic review.
Khanmohammadi S; Fallahtafti P
J Cell Mol Med; 2023 Jul; 27(14):1928-1946. PubMed ID: 37246627
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity.
Peng W; Fan H; Wu G; Wu J; Feng J
Clin Exp Med; 2016 May; 16(2):177-82. PubMed ID: 25864113
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.
Peng W; Feng J
Biomed Pharmacother; 2016 Feb; 77():65-71. PubMed ID: 26796267
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategy with artificially-designed i-lncRNA targeting multiple oncogenic microRNAs exhibits effective antitumor activity in diffuse large B-cell lymphoma.
Su Y; Sun B; Lin X; Zhao X; Ji W; He M; Qian H; Song X; Yang J; Wang J; Chen J
Oncotarget; 2016 Aug; 7(31):49143-49155. PubMed ID: 27172795
[TBL] [Abstract][Full Text] [Related]
16. [Research on Ralation of Long Non-coding RNA with Diffuse Large B-cell Lymphomas -Review].
Wu YY; Xing YR; Yu DN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):609-614. PubMed ID: 29665941
[TBL] [Abstract][Full Text] [Related]
17. Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis.
Ansari H; Shahrisa A; Birgani YT; Birgani MT; Hajjari M; Asl JM
Pathol Oncol Res; 2019 Oct; 25(4):1387-1394. PubMed ID: 29948619
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling reveals an integrated mRNA-lncRNA signature with predictive value for long-term survival in diffuse large B-cell lymphoma.
Gao Q; Li Z; Meng L; Ma J; Xi Y; Wang T
Aging (Albany NY); 2020 Nov; 12(22):23275-23295. PubMed ID: 33221755
[TBL] [Abstract][Full Text] [Related]
19. Relapsed diffuse large B-cell lymphoma present different genomic profiles between early and late relapses.
Broséus J; Chen G; Hergalant S; Ramstein G; Mounier N; Guéant JL; Feugier P; Gisselbrecht C; Thieblemont C; Houlgatte R
Oncotarget; 2016 Dec; 7(51):83987-84002. PubMed ID: 27276707
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma.
Birgani MT; Hajjari M; Shahrisa A; Khoshnevisan A; Shoja Z; Motahari P; Farhangi B
Pathol Oncol Res; 2018 Apr; 24(2):329-337. PubMed ID: 28508329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
